Ubs Asset Management Americas Inc Neogenomics Inc Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 497,451 shares of NEO stock, worth $3.62 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
497,451
Previous 646,111
23.01%
Holding current value
$3.62 Million
Previous $10.6 Million
55.67%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding NEO
# of Institutions
288Shares Held
127MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$143 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$104 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$48.9 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$44 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$41.8 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $916M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...